Vascular Grafts Market Size, Growth, Price Trends, Report 2024-2032

Comments · 47 Views

The global market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

IMARC Group, a leading market research company, has recently releases report titled “Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032” offers a comprehensive analysis of the industry, which comprises insights on the vascular grafts industry size. The global market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Request For Sample Copy of Report For More Detailed Market insight:

Factors Affecting the Growth of the Vascular Grafts Industry:

  • Prevalence of Cardiovascular Diseases:

The increasing incidence of cardiovascular diseases (CVDs) worldwide represents one of the crucial factors impelling the market growth. These diseases often necessitate surgical interventions that utilize vascular grafts.

  • Technological Advancements in Graft Materials and Design:

The ongoing technological advancements in graft materials and design are supporting the market growth. Modern vascular grafts are biocompatible, durable, and designed to minimize complications like infections and graft rejection. The growing number of innovations, such as drug-eluting grafts and tissue-engineered vascular grafts, which are designed to integrate more seamlessly with the own tissues of the body, are offering a favorable market outlook. These advancements enhance the effectiveness and safety of vascular surgeries, leading to improved patient outcomes.

  • Preference for Minimally Invasive Surgeries (MIS):

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth. MIS procedures, which include endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), are less traumatic than traditional open surgeries and offer benefits like reduced hospital stay, lower risk of infections, and quicker recovery. This is encouraging the development and adoption of specialized vascular grafts suitable for these procedures. Additionally, patients and healthcare providers are increasingly favoring MIS due to these advantages, leading to the demand for compatible vascular grafts.

Leading Companies Operating in the Global vascular grafts Industry:

  • Abbott Laboratories
  • B. Braun SE (B. Braun Holding GmbH Co. KG)
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Cordis
  • CryoLife Inc.
  • Getinge AB
  • Heat Medical Europe BV
  • LeMaitre Vascular
  • Medtronic plc
  • Terumo Corporation
  • W. L. Gore Associates Inc.

Vascular Grafts Market Report Segmentation:

By Product:

  • Endovascular Stent Grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-Pass Grafts
  • Vascular Grafts for Aorta Disease
  • Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

By Raw Material:

  • Polytetrafluoroethylene (PTFE)
  • Polyester
  • Polyurethane
  • Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Global Vascular Grafts Market Trends:

The rising advancements in medical imaging and 3D printing technology are making it possible to design grafts that are tailored to the individual anatomy and needs of each patient. This personalized approach not only improves the compatibility and effectiveness of the grafts but also reduces the risk of complications, such as thrombosis or graft occlusion.

Besides this, the growing integration of smart technologies in vascular grafts is positively influencing the market. These smart grafts are equipped with sensors and other technologies that allow for real-time monitoring of graft performance and vascular health. This innovation enables early detection of potential issues.

Other Key Points Covered in the Report:

  • COVID-19 Impact
  • Porters Five Forces Analysis
  • Value Chain Analysis
  • Strategic Recommendations

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Read more